Terms: = Thyroid cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309
7 results:
1. Role of oncogene pim-1 in the development and progression of papillary thyroid carcinoma: Involvement of oxidative stress.
Wen QL; Yi HQ; Yang K; Yin CT; Yin WJ; Xiang FY; Bao M; Shuai J; Song YW; Ge MH; Zhu X
Mol Cell Endocrinol; 2021 Mar; 523():111144. PubMed ID: 33383107
[TBL] [Abstract] [Full Text] [Related]
2. JAK/STAT3 and NF-κB Signaling Pathways Regulate cancer Stem-Cell Properties in Anaplastic thyroid cancer Cells.
Shiraiwa K; Matsuse M; Nakazawa Y; Ogi T; Suzuki K; Saenko V; Xu S; Umezawa K; Yamashita S; Tsukamoto K; Mitsutake N
Thyroid; 2019 May; 29(5):674-682. PubMed ID: 30784360
[No Abstract] [Full Text] [Related]
3. RETRACTED: Physcion 8-O-β-glucopyranoside suppresses tumor growth of Hepatocellular carcinoma by downregulating pim1.
Wang Q; Jiang Y; Guo R; Lv R; Liu T; Wei H; Ming H; Tian X
Biomed Pharmacother; 2017 Aug; 92():451-458. PubMed ID: 28570979
[TBL] [Abstract] [Full Text] [Related]
4. Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of pim1 mediated by PKM2 and LncRNA CUDR.
Wu M; An J; Zheng Q; Xin X; Lin Z; Li X; Li H; Lu D
Oncotarget; 2016 Oct; 7(41):66525-66539. PubMed ID: 27167190
[TBL] [Abstract] [Full Text] [Related]
5. MicroRNA-486-5p targeting pim-1 suppresses cell proliferation in breast cancer cells.
Zhang G; Liu Z; Cui G; Wang X; Yang Z
Tumour Biol; 2014 Nov; 35(11):11137-45. PubMed ID: 25104088
[TBL] [Abstract] [Full Text] [Related]
6. Aberrant somatic hypermutations in thyroid lymphomas.
Takakuwa T; Miyauchi A; Aozasa K
Leuk Res; 2009 May; 33(5):649-54. PubMed ID: 19019431
[TBL] [Abstract] [Full Text] [Related]
7. De novo malignances in pediatric organ transplant recipients.
Penn I
Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
[TBL] [Abstract] [Full Text] [Related]
